Lyfe Rx Review

What Lyfe Rx charges

• PT-141: $225 — a bare storefront figure; the listing names no billing period
• Glutathione: $250 — a bare storefront figure; a separate "Glutathione Protocol" is listed at $215.00 on the same page
• NAD+: $250 — a bare storefront figure; a separate "NAD+ Optimization Protocol" is listed at $240.00 on the same page
• Sermorelin: $250 — from; the collection page names no billing period

The federal letter names its own website

The letter's opening line says the agency reviewed the website content at this seller's own internet address in August 2025 and observed that the site offers various compounded drug products, including semaglutide and tirzepatide.

The recipient address on the letter is in Bee Cave, Texas, which is this seller and not one of the other rows the federal table returns for a similar name.

That is why the letter is filed here: it was confirmed from the letter body, not from a name match.

Open prices with no billing period attached

Its collection page lists bremelanotide, a glutathione nasal spray, a glutathione protocol, an NAD+ nasal spray and an NAD+ protocol as bare figures in a product list.

There is no per-month marker, no supply length and no cycle printed against any of them.

Every one of those rows is recorded here as not monthly, because the seller never says it is.

Two prices for one compound, with nothing to separate them

Glutathione appears twice on the same page — as a nasal spray and as a protocol — at two different figures.

NAD+ does the same thing, a nasal spray and an optimization protocol at two different figures.

The page does not say what a protocol contains that the spray does not, so a reader cannot tell which one they are being quoted.

What it says about itself

In its own words: "Many Lyfe RX protocols are compounded medications, not FDA-approved drugs. Compounded drugs are not reviewed by the FDA for safety, effectiveness, or quality, and are not generic or equivalent versions of FDA-approved products."

It also says "Lyfe RX is a telehealth platform, not a pharmacy, and does not prescribe any product directly."

It says every prescription is prepared by a United States licensed 503A compounding pharmacy, which names a class rather than a pharmacy, and no certificate of analysis is published.

FDA disclosure

Lyfe Rx received an FDA warning letter issued September 2025. A warning letter discloses; it does not, on its own, disqualify a provider — see the trade-offs above for what this one concerned.

How we verified this

• Read the collection pages and confirmed each figure is printed as a bare storefront number with no billing period beside it, then recorded every one as not monthly.
• Read the sermorelin figure in both places it is printed on the hormone collection, confirmed the two are the same number, and recorded it once.
• Took the seller's statements on legal category and on what it is from its own pages, and quoted them rather than paraphrasing.
• Requested a deliberately meaningless address on this host in the same session and confirmed it returns a not-found response.
• Confirmed the federal warning letter from its own opening line, which names this seller's website address, rather than from a name match against the federal table.